Related Experiment Video
Updated: Jul 25, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
Incidence of hepatitis A virus (HAV) infection in rural Liberia
Insights
Hepatitis A virus (HAV) infection is extremely common in Liberian children, with nearly all infected by age four. This high incidence provides an excellent opportunity for future hepatitis A vaccine trials.
Area of Science:
- * Virology and Immunology
- * Infectious Diseases Epidemiology
Background:
- * Hepatitis A virus (HAV) poses a significant global health burden.
- * Understanding HAV epidemiology in young populations is crucial for vaccine development.
Purpose of the Study:
- * To establish baseline data on antibody to hepatitis A virus (anti-HAV) prevalence and incidence in Liberian infants and children.
- * To inform the design and feasibility of future hepatitis A vaccine efficacy trials in this region.
Main Methods:
- * Sera were collected from Liberian infants (0-4 years) and their mothers at two time points, approximately 14.75 months apart.
- * Antibody to hepatitis A virus (anti-HAV) was tested using serological assays.
- * Hepatitis B virus (HBV) infection status was also assessed.
Main Results:
- * Anti-HAV prevalence increased from 2.5% in 0-6 month olds to 70% in 3-4 year olds.
- * Annual incidence of new HAV infections was 35% in the first year and averaged 45% in subsequent years.
- * Hepatitis B virus infection did not impact HAV seroconversion rates; dual infections were clinically inapparent.
Conclusions:
- * Liberian children experience an exceptionally high incidence of hepatitis A virus infection.
- * The study population is well-suited for vaccine efficacy trials due to the high infection rate.
- * No clinical illness was observed in subjects who seroconverted or had dual HAV/HBV infections.
Abstract:
To provide background for future hepatitis A vaccine trials, sera were collected from 0- to 4-year-old Liberian infants and their mothers on two occasions an average of 14.75 months apart and tested for antibody to hepatitis A virus (anti-HAV). The prevalence of anti-HAV rose from 2.5% in infants 0-6 months of age to 70% in children 3-4 years of age and did not differ between male and female infants. The annual incidence of new infections was slightly lower in the first year of life (35%) than in the subsequent 3 years, when it averaged 45%. The presence of HBV infection did not affect the incidence of HAV seroconversion. No clinical hepatitis was recognized in the subjects who seroconverted. Dual hepatitis A and B virus infection were observed; these were all clinically inapparent. The extraordinary incidence of HAV infection documented in the present study offers an opportunity for vaccine efficacy trials requiring minimal numbers of subjects.
Related Concept Videos
Infectious Diseases and Their Occurrence
Poliomyelitis
Yellow Fever
Hepatitis
Viral Hepatitis I: Introduction

